Makindo Medical Notes"One small step for man, one large step for Makindo" |
![]() |
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
๐ก Key Pearls:
โญ AV fistula = longest survival, lowest infection.
๐ซ Never use fistula arm for BP, bloods, or IV lines.
๐ซ Avoid subclavian lines (stenosis risk).
๐ Urgently refer access issues to vascular team.
๐ Central Venous Catheter (CVC)
โ๏ธ Immediate access, no maturation needed.
โ Infection + thrombosis, poor long-term patency, central stenosis.
โก๏ธ Used for AKI, bridging, or unsuitable for fistula/graft.
๐ Arteriovenous (AV) Fistula
โ๏ธ Best long-term survival, lowest infection, high flow.
โ 4โ8 wks to mature, failure to mature (โค30%), steal syndrome, aneurysm, high-output failure.
โก๏ธ Gold standard for chronic haemodialysis.
๐ AV Graft (Synthetic ePTFE)
โ๏ธ Can use in 2โ3 weeks, option if poor veins.
โ More infection, poorer patency than fistula, frequent re-interventions.
โก๏ธ For patients with poor native vessels (elderly, diabetics).
๐ Infection risk: CVC > Graft > Fistula
๐ Patency/survival: Fistula > Graft > CVC
๐ Always confirm thrill + bruit before use